Theralase Technologies Inc. V.TLT

Prelim Results

[monte2016]

There is a graph with incomplete prelim results.  For those that are experienced in these biotech plays...what is your opinion on these results?  90 day shows 33.3 CR and that is down to 11.1 for 360 days and 450. Are these numbers high enough for CR to excite the medical community?  Your thoughts would be appreciated. Thanks.

[99942Apophis]

monte2016 wrote There is a graph with incomplete prelim results.  For those that are experienced in these biotech plays...what is your opinion on these results?  90 day shows 33.3 CR and that is down to 11.1 for 360 days and 450. Are these numbers high enough for CR to excite the medical community?  Your thoughts would be appreciated. Thanks. The numbers at 360 & 450 are of the

[O12009]

  If you search on their web site for news letter you can see the results for the last six that were treated with the optimize treatment. 2 complete response 33.3% 1 no response 16.7% 3 pending 50% so it is possible at 90 days if the last 3 were CR we could be as high as 83.3% CR. if 2 of the last 3 were CR we would be 66.7 CR if 1 of the last 3 were CR we would be 50% CR

[judgesmails]

Thank you for the comments about the numbers, folks.  I'm more optimistic after reading the various analyses here than I was when I first looked at the quarterly report. Cheers, judgemails

[gojotv!]

You're not reading that graph right, monte. The results aren't "down to 11.1 for 360 days and 450". The results for the totality of patients are largely PENDING for days 360 and 450, because most patients weren't treated that long ago, or their results aren't fully analyzed yet. So, yeah, when you see the very robust duration of this treatment's efficacy, it's

[enriquesuave]

Out of 15 patients they minimum CR at 90 days is 33% and maximum is 91.7% ( would have been 100% if patient that sadly passed away had survived).  if all pending and partial responders become CR once evaluated.  At 180 days, the minimum is 20% (3 patients) and maximum 80% etc. Looking very good compared to competition as potential to vastly surpass efficacy is there just hope that

[CancerSlayer]

  Yep....in my analysis, the 90 day CR minimum was 33% & maximum was 83% with 1 PR based on the 15 optimized patients....with the potential for 91.6%, discounting the 1 NR.  The data is indeed looking reassuring & my hope is that the pending patients fare "better" than the non-pending.  If they fared as well, that would only give us a 50% CR at 180 days